Vienna - Delayed Quote EUR
CME Group Inc. (CMEG.VI)
232.10
-1.45
(-0.62%)
At close: April 25 at 5:32:29 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 14 | 15 |
| Avg. Estimate | 1.67B | 1.61B | 6.54B | 6.84B |
| Low Estimate | 1.61B | 1.55B | 6.25B | 6.34B |
| High Estimate | 1.74B | 1.66B | 6.98B | 7.54B |
| Year Ago Sales | 1.53B | 1.58B | 6.13B | 6.54B |
| Sales Growth (year/est) | 8.94% | 1.75% | 6.72% | 4.59% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CMEG.VI | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 4/25/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 4/24/2025 |
| Maintains | Keefe, Bruyette & Woods: Market Perform to Market Perform | 4/24/2025 |
| Maintains | JP Morgan: Underweight to Underweight | 4/24/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/23/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 4/11/2025 |